Clinical Trial Update: Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating afatinib plus letrozole versus letrozole alone for breast cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Afatinib (afatinib)
• Letrozole (letrozole)

Snippet

Sponsor: Translational Research in Oncology | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2019-12-26